Brief: Tot Biopharm International Says HY Loss Attributable Rmb115 Million
12/08/2021 16:27
Aug 12 (Reuters) - TOT BIOPHARM International Co Ltd
1875.HK :
* TOT BIOPHARM INTERNATIONAL SAYS HY LOSS ATTRIBUTABLE
RMB115
MILLION VERSUS LOSS RMB129.2 MILLION
* TOT BIOPHARM INTERNATIONAL - HY REVENUE WAS RMB23.1
MILLION, UP
78% YOY
Source text for Eikon: ID:
Further company coverage: 1875.HK
(Reuters.briefs@thomsonreuters.com)
Recent news on BioDlink International
See all newsCorrected: China's BioDlink International HY revenue falls (September 29)
Brief: Biodlink International To Deliver Ten Batches Of Monoclonal Antibody Intermediates To Wuxi Biologics
Brief: Biodlink International Says Shan Fu Resigns As Executive Director And Chairperson
Brief: BioDlink International Says WuXi XDC Cayman To Make Conditional Cash Offer For All Co Shares
Brief: HKEX Says Trading In Shares Of Biodlink International Will Be Halted At Dec 29